Eyecare workforce is 'adequate' for current and projected demand
June 23rd 2014The American Optometric Association (AOA) and the Association of Schools and Colleges of Optometry (ASCO) recently released results of the National Eyecare Workforce Study. The study aimed to answer questions about how U.S. eye health needs will be met over the next decade.
Visit with Dr. Ernie Bowling at booth 1433
June 20th 2014Heading to the American Optometric Association meeting in Philadelphia on June 25-29? Optometry Times Chief Optometric Editor Dr. Ernie Bowling will be at the Optometry Times booth #1433 from 5-6 pm Thursday; 3-4pm Friday; and 10-11am Saturday. Stop by and say hi!
Editor Gretchyn Bailey invites you to attend the Optometry Times reception at AOA
June 20th 2014Optometry Times Editor Gretchyn Bailey invites you to drop by the Optometry Times reception! The reception will be held from 9-11 pm Thursday, June 26, at the Hotel Monaco in the rooftop lounge. Please join us for dessert and drinks! The hotel's address is 433 Chestnut Street in the heart of Old City and steps away from the Liberty Bell.
Study: coefficient of friction of 1-Day Acuvue TruEye, Acuvue Oasys comparable to human cornea
June 17th 2014According to research presented at the 2014 British Contact Lens Association Clinical Conference, found the coefficient of friction of the 1-Day Acuvue TruEeye and Acuvue Oasys brand contact lenses were comparable to that of the human cornea.
Federal court finds two Latisse patents invalid
June 16th 2014The U.S. Court of Appeals for the Federal Circuit in Washington, D.C. recently found a pair of patents for Allergan’s Latisse (bimatoprost) invalid and threw out an order preventing Novartis’ Sandoz unit, Actavis, and generic drug company Apotex Inc. from selling their versions of the eyelash growth drug.
Study: using Avastin to treat AMD, DME could save Medicare billions
June 9th 2014A study from the University of Michigan, which was recently published in Health Affairs, found that if all eyecare practitioners (ECPs) prescribed Avastin (bevacizumab, Genentech) instead of the more-expensive Lucentis (ranibizumab, Genentech) for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME), Medicare plans could save $18 billion over a 10-year period.
Study ranks cities with happiest patients
June 5th 2014A study of more than 46,000 online physician reviews finds patients in the San Francisco and Oakland, CA, area are happiest with their health care, while patients in Bakersfield, CA, are the least satisfied with their health care, according to Vanguard Communications.